Christine Ann Poon
Lead Independent DirectorMs. Christine Ann Poon, also known as Chris, serves as Independent Director at Neurocrine Biosciences, Inc. since July 2023. She has been an Independent Director of Regeneron Pharmaceuticals, Inc. since November 2010 and serves its Lead Independent Director since June 2023. Ms. Poon had been an Independent Director of Decibel Therapeutics, Inc. since May 2019 until December 3, 2021. Ms. Poon was named Woman of the Year by the Healthcare Businesswomen’s Association in 2004 and named Business Leader of the Future by CNBC/Wall Street Journal in 2005. Ms. Poon has served as an Executive-in-Residence in the Department of Management and Human Resources at The Max M. Fisher College of Business at The Ohio State University since September 2015. She served as Professor of Management and Human Resources at The Max M. Fisher College of Business from October 2014 to September 2015. She has been a Senior Advisor of Healthcare Banking at Barclays PLC until December 2015. She had been Member of Advisory Board at Saama Technologies, Inc. until 2022. Ms. Poon served as a Secretary of Koninklijke Philips N.V. Ms. Poon served as the Dean and John W. Berry, Sr. Chair of Business at The Max M. Fisher College of Business at The Ohio State University from April 2009 to October 2014. Ms. Poon was employed at Kate Spade & Company (also known as Fifth & Pacific Companies, Inc.). Her areas of expertise include domestic and international business operations and sales and marketing. Prior to joining Ohio State, she worked at Johnson & Johnson until her retirement in March 2009. She has extensive strategic and operational leadership skills. Prior to Johnson & Johnson, she held various senior leadership positions at Bristol-Myers Squibb Company. She served as the President of International Medicines of Bristol-Myers Squibb Company from 1998 to 2000 and also served as its President of Medical Devices from 1997 to 1998. Ms. Poon joined Johnson & Johnson in 2000 as Company Group Chair in the Pharmaceuticals Group. She served as the Worldwide Chairman of Medicines & Nutritionals of Johnson & Johnson from 2003 to 2005. She served as the Worldwide Chairman of Pharmaceuticals Group of Johnson & Johnson from 2001 to January 1, 2009 and served as Worldwide Chair, Medicines and Nutritionals, from 2003 to 2005. She served as Vice Chairwoman of the Supervisory Board at Koninklijke Philips N.V until May 6, 2021. She served as Vice Chair and Director of Johnson & Johnson from January 12, 2005 to March 1, 2009. She has extensive expertise in domestic and international business operations, including sales and marketing and commercial operations and has deep strategic and operational knowledge in the pharmaceutical industry. Ms. Poon serves on the Supervisory Board of Royal Philips Electronics. She had been an Independent Director of The Sherwin-Williams Company since April 16, 2014 until April 2025. She has been an Independent Director of Prudential Financial, Inc., since September 1, 2006 and served as its Lead Independent Director since May 12, 2020 until 2023. She has been a Member of Supervisory Board at Philips Electronics Australia Limited since 2009. She was a Member of the Supervisory Board at Koninklijke Philips N.V until May 6, 2021. She has been a Member of the Supervisory Board at Philips Malaysia Sdn. Bhd since 2009. She has been a Director of September 18, 2015. She serves as a Director at The Prudential Insurance Company of America. She serves as a Director of The Fox Chase Cancer Center in Philadelphia PA. She serves as a Member of the Advisory Board of the Healthcare Businesswomen's Association. She served as a Director of US-China Business Council, Inc. and Kate Spade & Company. Ms. Poon holds a BA from Northwestern University in Biology in 1973, an M.S. in Biology and Biochemistry at St. Louis University in 1976 and an MBA in Finance from Boston University in 1982.
Positions
- Company NameRegeneron Pharmaceuticals, Inc.Stock CodeREGNPositionLead Independent DirectorColleagues
- LSLeonard S. SchleiferCo-Founder, President, CEO & Co-Chairman
- GDGeorge D. YancopoulosCo-Founder, President, Chief Scientific Officer & Co-Chairman
- CRChristopher R. FenimoreExecutive VP of Finance & CFO
- JJJoseph J. LaRosaExecutive VP, General Counsel & Secretary
- AJAndrew J. MurphyExecutive VP of Research & Co-Chief Scientific Officer
- GLGeorge L. SingIndependent Director
- JLJoseph L. GoldsteinIndependent Director
- Company NamePrudential Financial, Inc.Stock CodePRUPositionIndependent DirectorColleagues
- AFAndrew Francis SullivanChairman, CEO & President
- YDYanela del Carmen FriasExecutive VP & CFO
- SEScott E. CaseExecutive VP & Head of Global Technology and Operations
- JPJacques Philppe ChappuisPresident & CEO of PGIM Inc.
- MJMatthew J. ArmasSenior VP & Chief Investment Officer
- GFGilbert Fran CasellasIndependent Director
- CAChristine Ann PoonIndependent Director
- MTMartina Therese Sophie Hund-MejeanIndependent Director
- SPSandra PianaltoIndependent Director
